Q: What piece of advice would you like to give people about revenue integrity?
Hirsch: Prevention is so much easier in the long run. That effort will pay off significantly over time.
Most hospitals are noncompliant with CMS’ Hospital Price Transparency final rule, according to a study published June 14 in JAMA. Out of a random sample of 100 hospitals, 83 were noncompliant with at least one significant requirement.
Q: What’s the biggest challenge in revenue integrity right now?
Goodman: One of the biggest challenges at the moment is simply keeping revenue integrity at the forefront while so many entities are still recovering from the public health emergency and trying to do more with less.
CMS announced an increase in Medicare payment for at-home administration of COVID-19 vaccines. Medicare will now pay $75 per at-home dose, nearly double its previous $40 adminitration rate.
CMS boosted Medicare payment for COVID-19 vaccines administered in the patient’s home to $75 per dose, the agency announced June 9. Prior to June 9, Medicare paid $40 per dose for COVID-19 vaccines administered in the patient’s home.
NAHRI supports the professional accomplishments of all its members and the revenue integrity community at large. If you know a revenue integrity professional who has gone above and beyond in their role—be it a promotion, great idea, or helping hand—we want to help you give them a shout out.
Jugna J. Shah, MPH, CHRI, discusses why innovative therapies and technologies call for innovations in existing coding, billing, and reimbursement models.
